|
National Stock Number(NSN): 6505-01-031-4983 (6505010314983, 010314983)
| NIIN: |
01-031-4983 |
Item Name: |
ISOSORBIDE DINITRATE TABLETS |
INC: |
26484
|
| FSC: |
6505
|
Assignment Date: |
Nov-24-1976 |
CRIT: |
N |
IIG: |
26484 |
| ISC: |
5 |
Date Standardized: |
Nov-24-1976 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-05-2003 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
0029-20 |
65751
|
MYLAN INSTITUTIONAL INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
ISORDIL TITRADOSE E.Z. SPLIT CLI |
14706
|
IVES LABORATORIES INC |
H |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
|
NDC00008-4153-04 |
04543
|
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV |
H |
3 |
1 |
|
|
|
|
|
|
|
|
|
NDC00008-4153-05 |
04543
|
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00143-1771-25 |
32655
|
HIKMA PHARMACEUTICALS USA INC. |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00310-0078-39 |
0A273
|
ASTRAZENECA LP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC51079-0029-20 |
65751
|
MYLAN INSTITUTIONAL INC |
H |
5 |
9 |
4 |
54 |
|
B |
|
|
|
|
|
SORBITRATE |
0A273
|
ASTRAZENECA LP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
SORBITRATE TABLETS |
0A273
|
ASTRAZENECA LP |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
Q |
U |
1 |
A |
$1.77 |
PG |
|
C2201X- |
Feb-01-2002 |
H |
| DF |
JDC |
L |
|
Q |
U |
1 |
F |
$1.77 |
PG |
|
------- |
Aug-01-1997 |
H |
| DN |
JDC |
Y |
|
Q |
U |
1 |
N |
$1.77 |
PG |
|
9L----- |
May-01-2003 |
H |
| DS |
JDC |
L |
|
Q |
U |
1 |
D |
$1.77 |
PG |
|
------- |
Aug-01-1997 |
H |
| VA |
JVS |
I |
|
Q |
U |
0 |
V |
$0.00 |
PG |
|
------- |
Nov-01-1987 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 MILLIGRAMS ISOSORBIDE DINITRATE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
ISOSORBIDE DINITARATE TABLETS USP 10MG INDIVIDUALLY SEALED 100S |
| FEAT |
SPECIAL FEATURES |
NONCHEWABLE |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP FOR DOD,ICI AMERICAS INC. |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| YJ01 |
|
Oct-31-1994 |
|
|
|
|
YJ |
YJ |
Replacement & Obsolete Information
| Obsolete NIIN Information |
|